12 results
Statins intensity, drug interactions, timing of administration and missed doses.

An overview of high, moderate and low
Statins intensity, drug ... #pharmacology #overview ... #review #dosing ... #medications #comparison ... #drugs #table
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
are usually the drugs ... #pharmacology #comparison ... #treatment #medications ... #dosing #drugs ... #table #pharmacotherapy
Common sodium channel blockers which cause QRS widening.

Anticonvulsants: 
 - Carbamazepine 
Antidysrhythmics:  
 - Group
blockers which cause ... widening #ECG #EKG #Pharmacology ... #Medications #Toxicology ... #Diagnosis #Differential ... #Drugs #Classes
Creatine Kinase - Causes of Elevated CK Levels
Acute CK Elevation (Pain > Weakness):
 • RHABDOMYOLYSIS
Creatine Kinase - Causes ... RHABDOMYOLYSIS - Drugs ... alcohol - Medications ... Illness Myopathy (ICU ... #Elevated #CK #differential
Review of Intranasally Administered Medications for Use in the Emergency Department
Table of agents, uses, dosing, onset
Emergency Department Table ... of agents, uses ... , dosing, onset ... #Comparison #Table ... #Pharmacology #
Vasopressors and Inotropes
 • Norepinephrine - Levophed - "Levo" - Generally thought of as the first
common in OR; in MICU ... criticalcare #summary #comparison ... #table #pharmacology ... #indications
Intern Pocket Cards - Inpatient Bowel Regimen Guide
Osmotic agents (draws water into bowel, thereby loosening stool
Polyethylene glycol - Nausea ... Guide #Inpatient #medications ... #constipation #pharmacology ... #table #agents ... #internship #comparison
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
and sodium • Dosing ... and calcium • Dosing ... #Hyperkalemia #medications ... #pharmacology # ... table #comparison
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug ... Eosinophils < 100 Dosing ... : 250 mcg tablet ... the use of this medication ... #Pharmacology #
Pharmaceutical agents other than olmesartan have been reported to cause villous atrophy on occasion and are
are listed in Table ... of drug-induced ... #Pharmacology #Drugs ... #Induced #Medications ... #Differential #